- Home
- BMRN vs FHN Comparison
BMRN vs FHN Comparison
Compare BMRN & FHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- FHN
- Stock Information
- Founded
- BMRN 1996
- FHN 1864
- Country
- BMRN United States
- FHN United States
- Employees
- BMRN N/A
- FHN N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- FHN Major Banks
- Sector
- BMRN Health Care
- FHN Finance
- Exchange
- BMRN Nasdaq
- FHN Nasdaq
- Market Cap
- BMRN 11.3B
- FHN 11.0B
- IPO Year
- BMRN 1999
- FHN N/A
- Fundamental
- Price
- BMRN $57.77
- FHN $22.26
- Analyst Decision
- BMRN Buy
- FHN Buy
- Analyst Count
- BMRN 23
- FHN 17
- Target Price
- BMRN $93.14
- FHN $23.32
- AVG Volume (30 Days)
- BMRN 1.8M
- FHN 10.1M
- Earning Date
- BMRN 10-28-2025
- FHN 10-15-2025
- Dividend Yield
- BMRN N/A
- FHN 2.69%
- EPS Growth
- BMRN 154.69
- FHN 28.04
- EPS
- BMRN 3.40
- FHN 1.55
- Revenue
- BMRN $3,063,608,000.00
- FHN $3,083,000,000.00
- Revenue This Year
- BMRN $13.32
- FHN $10.95
- Revenue Next Year
- BMRN $9.37
- FHN $3.68
- P/E Ratio
- BMRN $16.97
- FHN $14.41
- Revenue Growth
- BMRN 18.36
- FHN 4.62
- 52 Week Low
- BMRN $52.93
- FHN $14.83
- 52 Week High
- BMRN $90.01
- FHN $23.00
- Technical
- Relative Strength Index (RSI)
- BMRN 48.39
- FHN 51.21
- Support Level
- BMRN $55.99
- FHN $22.08
- Resistance Level
- BMRN $59.79
- FHN $22.98
- Average True Range (ATR)
- BMRN 1.37
- FHN 0.44
- MACD
- BMRN -0.05
- FHN -0.00
- Stochastic Oscillator
- BMRN 46.84
- FHN 51.67
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.